{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:19:08Z","timestamp":1792300748488,"version":"4.4.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.semcancer.2021.03.018","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T03:49:08Z","timestamp":1616471348000},"page":"56-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Does the \u201cDevil\u201d originate from the fallopian tubes?"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8414-4145","authenticated-orcid":false,"given":"Khalid","family":"El Bairi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouissam","family":"Al Jarroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8020-1544","authenticated-orcid":false,"given":"C\u00e9cile","family":"Le Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Afqir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.semcancer.2021.03.018_bib0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.semcancer.2021.03.018_bib0010","doi-asserted-by":"crossref","first-page":"R411","DOI":"10.1530\/ERC-16-0209","article-title":"Redefining the origin and evolution of ovarian cancer: a hormonal connection","volume":"23","author":"Cardenas","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"issue":"Suppl 8","key":"10.1016\/j.semcancer.2021.03.018_bib0015","doi-asserted-by":"crossref","first-page":"viii28","DOI":"10.1093\/annonc\/mdt308","article-title":"Coming into focus: the nonovarian origins of ovarian cancer","volume":"24","author":"Dubeau","year":"2013","journal-title":"Ann. Oncol."},{"issue":"476","key":"10.1016\/j.semcancer.2021.03.018_bib0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2020.02.017","article-title":"Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: mechanisms and therapeutic implications","volume":"28","author":"Bergsten","year":"2020","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.semcancer.2021.03.018_bib0025","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1158\/1078-0432.CCR-12-3947","article-title":"Early telomere shortening and genomic instability in tubo-ovarian preneoplastic lesions","volume":"19","author":"Chene","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.03.018_bib0035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.semcancer.2021.03.018_bib0045","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/bjc.2016.80","article-title":"Tubal ligation and incidence of 26 site-specific cancers in the million women study","volume":"114","author":"Gaitskell","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2021.03.018_bib0050","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ijc.29856","article-title":"Tubal ligation and ovarian cancer risk in a large cohort: substantial variation by histological type","volume":"138","author":"Gaitskell","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2021.03.018_bib0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies","volume":"42","author":"Sieh","year":"2013","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.03.018_bib0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.semcancer.2021.03.018_bib0065","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.03.018_bib0080","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.semcancer.2021.03.018_bib0085","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.03.018_bib0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0095","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PAS.0000000000000353","article-title":"Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas","volume":"39","author":"Gilks","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.semcancer.2021.03.018_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2020.07.101","article-title":"Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: a memorial sloan kettering team ovary study","author":"Boerner","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.semcancer.2021.03.018_bib0105","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1016\/j.celrep.2019.10.122","article-title":"A study of high-grade serous ovarian Cancer origins implicates the SOX18 transcription factor in tumor development","volume":"29","author":"Lawrenson","year":"2019","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.semcancer.2021.03.018_bib0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2019.08.029","article-title":"Defining the molecular evolution of extrauterine high grade serous carcinoma","volume":"155","author":"Beirne","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.semcancer.2021.03.018_bib0115","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8659754","article-title":"Tubal origin of \u201cOvarian\u201d low-grade serous carcinoma: a gene expression profile study","volume":"2019","author":"Wang","year":"2019","journal-title":"J. Oncol."},{"issue":"11","key":"10.1016\/j.semcancer.2021.03.018_bib0120","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-18-0009","article-title":"Fallopian tube lesions in women at high risk for ovarian Cancer: a multicenter study","volume":"11","author":"Visvanathan","year":"2018","journal-title":"Cancer Prev. Res. (Phila)"},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.5145","article-title":"Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas","volume":"246","author":"Soong","year":"2018","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0135","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ygyno.2017.09.029","article-title":"Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium","volume":"147","author":"Qiu","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.semcancer.2021.03.018_bib0140","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","article-title":"Next-generation sequencing of tubal intraepithelial carcinomas","volume":"1","author":"McDaniel","year":"2015","journal-title":"JAMA Oncol."},{"issue":"11","key":"10.1016\/j.semcancer.2021.03.018_bib0145","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/modpathol.2011.106","article-title":"Tubal origin of\u2019 ovarian\u2019 low-grade serous carcinoma","volume":"24","author":"Li","year":"2011","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.semcancer.2021.03.018_bib0150","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.semcancer.2021.03.018_bib0155","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2741\/4044","article-title":"Telomere dysfunction and genome instability","volume":"17","author":"Frias","year":"2012","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrm2848","article-title":"Telomeres: protecting chromosomes against genome instability","volume":"11","author":"O\u2019Sullivan","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2021.03.018_bib0165","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1038\/srep06116","article-title":"Ovulation and extra-ovarian origin of ovarian cancer","volume":"4","author":"Yang-Hartwich","year":"2014","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0170","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/s41467-020-16432-0","article-title":"Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids","volume":"11","author":"L\u00f5hmussaar","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0175","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.semcancer.2021.03.018_bib0180","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00404-017-4529-z","article-title":"Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?","volume":"296","author":"Klotz","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0185","first-page":"13","article-title":"Tubal origin of ovarian low-grade serous carcinoma","volume":"1","author":"Chen","year":"2013","journal-title":"Am. J. Clin. Exp. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.semcancer.2021.03.018_bib0190","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.semcancer.2021.03.018_bib0195","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.semcancer.2021.03.018_bib0200","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1593\/neo.11138","article-title":"Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma","volume":"13","author":"Jazaeri","year":"2011","journal-title":"Neoplasia"},{"issue":"10","key":"10.1016\/j.semcancer.2021.03.018_bib0205","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.semcancer.2021.03.018_bib0210","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.semcancer.2021.03.018_bib0215","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/cancers10080262","article-title":"UnPAXing the divergent roles of PAX2 and PAX8 in high-grade serous ovarian Cancer","volume":"10","author":"Hardy","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.4927","article-title":"High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease [published correction appears in J Pathol. 2017 Oct;243(2):267]","volume":"243","author":"Zhai","year":"2017","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.semcancer.2021.03.018_bib0225","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/cancers11060884","article-title":"Loss of PTEN in fallopian tube epithelium results in multicellular tumor spheroid formation and metastasis to the ovary","volume":"11","author":"Dean","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/carcin\/bgy170","article-title":"Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer","volume":"40","author":"Dean","year":"2019","journal-title":"Carcinogenesis"},{"issue":"15","key":"10.1016\/j.semcancer.2021.03.018_bib0235","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s41388-017-0097-8","article-title":"PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation","volume":"37","author":"Russo","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2021.03.018_bib0240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2018.07.003","article-title":"Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model","volume":"433","author":"Karthikeyan","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2021.03.018_bib0245","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2017.01.011","article-title":"Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling","volume":"391","author":"Dean","year":"2017","journal-title":"Cancer Lett."},{"issue":"21","key":"10.1016\/j.semcancer.2021.03.018_bib0250","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/onc.2016.455","article-title":"PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer","volume":"36","author":"Modi","year":"2017","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.semcancer.2021.03.018_bib0255","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/path.4807","article-title":"Haemoglobin in pelvic fluid rescues Fallopian tube epithelial cells from reactive oxygen species stress and apoptosis","volume":"240","author":"Huang","year":"2016","journal-title":"J. Pathol."},{"issue":"40","key":"10.1016\/j.semcancer.2021.03.018_bib0260","doi-asserted-by":"crossref","first-page":"66077","DOI":"10.18632\/oncotarget.11808","article-title":"Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma","volume":"7","author":"Hua","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.semcancer.2021.03.018_bib0265","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/carcin\/bgv132","article-title":"Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.semcancer.2021.03.018_bib0270","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.29528","article-title":"Mutant p53 expression in fallopian tube epithelium drives cell migration","volume":"137","author":"Quartuccio","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.4875","article-title":"Tubal origin of ovarian cancer - the double-edged sword of haemoglobin","volume":"242","author":"Lin","year":"2017","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.semcancer.2021.03.018_bib0280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrendo.2015.36","article-title":"New insights in prolactin: pathological implications","volume":"11","author":"Bernard","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"23","key":"10.1016\/j.semcancer.2021.03.018_bib0285","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1158\/1078-0432.CCR-17-0638","article-title":"Integrated analysis reveals tubal- and ovarian-originated serous ovarian Cancer and predicts differential therapeutic responses","volume":"23","author":"Hao","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"Suppl 1","key":"10.1016\/j.semcancer.2021.03.018_bib0290","doi-asserted-by":"crossref","first-page":"i53","DOI":"10.1093\/annonc\/mdw087","article-title":"Mucinous epithelial ovarian carcinoma","volume":"27","author":"Perren","year":"2016","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.semcancer.2021.03.018_bib0295","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/1471-0528.16264","article-title":"Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data","volume":"127","author":"Irodi","year":"2020","journal-title":"BJOG"},{"issue":"11","key":"10.1016\/j.semcancer.2021.03.018_bib0300","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S1470-2045(11)70058-4","article-title":"Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma","volume":"12","author":"Kelemen","year":"2011","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0305","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12885-018-4242-8","article-title":"Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers","volume":"18","author":"Le Page","year":"2018","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.semcancer.2021.03.018_bib0310","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: recommendations for improving outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.semcancer.2021.03.018_bib0315","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/00000478-200307000-00014","article-title":"Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis","volume":"27","author":"Seidman","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.semcancer.2021.03.018_bib0320","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/PGP.0000000000000274","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"K\u00f6bel","year":"2016","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0325","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1038\/s41467-019-11862-x","article-title":"The molecular origin and taxonomy of mucinous ovarian carcinoma","volume":"10","author":"Cheasley","year":"2019","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.semcancer.2021.03.018_bib0330","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s41379-019-0302-0","article-title":"A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases","volume":"32","author":"Meagher","year":"2019","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.03.018_bib0335","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0340","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian Cancer survival by Histotype and disease stage","volume":"111","author":"Peres","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0345","first-page":"869","article-title":"Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma","volume":"5","author":"Wang","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2021.03.018_bib0350","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00404-020-05445-1","article-title":"Association between endometriosis and gynecological cancers: a critical review of the literature","volume":"301","author":"Kalaitzopoulos","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0355","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/modpathol.2011.143","article-title":"Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas","volume":"25","author":"Yamamoto","year":"2012","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.03.018_bib0360","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/modpathol.2011.189","article-title":"Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations","volume":"25","author":"Yamamoto","year":"2012","journal-title":"Mod. Pathol."},{"issue":"16","key":"10.1016\/j.semcancer.2021.03.018_bib0365","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0370","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ijc.21845","article-title":"Molecular genetic evidence that endometriosis is a precursor of ovarian cancer","volume":"119","author":"Prowse","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0375","first-page":"11","article-title":"Endometriosis and ovarian Cancer: an integrative review (Endometriosis and ovarian cancer)","volume":"18","author":"brilhante","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"5","key":"10.1016\/j.semcancer.2021.03.018_bib0380","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/IGC.0000000000000698","article-title":"BAF250a expression in atypical endometriosis and endometriosis-associated ovarian cancer","volume":"26","author":"Stamp","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"6","key":"10.1016\/j.semcancer.2021.03.018_bib0385","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.3892\/or.2014.3524","article-title":"RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis","volume":"32","author":"Guo","year":"2014","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.semcancer.2021.03.018_bib0390","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/modpathol.2013.245","article-title":"Tubal origin of ovarian endometriosis","volume":"27","author":"Yuan","year":"2014","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.semcancer.2021.03.018_bib0395","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.semcancer.2021.03.018_bib0400","first-page":"2207","article-title":"Synchronous endometrioid endometrial and ovarian carcinomas are biologically related: a clinico-pathological and molecular (next generation sequencing) study of 22 cases","volume":"17","author":"H\u00e1jkov\u00e1","year":"2019","journal-title":"Oncol. Lett."},{"issue":"20","key":"10.1016\/j.semcancer.2021.03.018_bib0405","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1093\/hmg\/ddv306","article-title":"Shared genetics underlying epidemiological association between endometriosis and ovarian cancer","volume":"24","author":"Lu","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0410","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1309\/AJCPZ5T2POOFMQVN","article-title":"Distinct \u03b2-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas","volume":"144","author":"Matsumoto","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.03.018_bib0415","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.humpath.2006.10.007","article-title":"Alternate molecular genetic pathways in ovarian carcinomas of common histological types","volume":"38","author":"Willner","year":"2007","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0420","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/path.4783","article-title":"Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse","volume":"240","author":"Wu","year":"2016","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.semcancer.2021.03.018_bib0425","doi-asserted-by":"crossref","first-page":"dju146","DOI":"10.1093\/jnci\/dju146","article-title":"Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis","volume":"106","author":"Guan","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2021.03.018_bib0430","doi-asserted-by":"crossref","DOI":"10.1002\/path.5136","article-title":"Distinct developmental trajectories of endometriotic epithelium and stroma: implications for the origins of endometriosis","author":"Lac","year":"2018","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0435","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1038\/s41467-019-11403-6","article-title":"ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion","volume":"10","author":"Wilson","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.semcancer.2021.03.018_bib0440","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.celrep.2018.07.037","article-title":"Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium","volume":"24","author":"Suda","year":"2018","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.semcancer.2021.03.018_bib0445","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.3390\/ijms21082824","article-title":"The potential role of complement system in the progression of ovarian clear cell carcinoma inferred from the gene ontology-based immunofunctionome analysis","volume":"21","author":"Su","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0450","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/humupd\/dmz047","article-title":"Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology","volume":"26","author":"Guo","year":"2020","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"10.1016\/j.semcancer.2021.03.018_bib0455","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/path.5308","article-title":"Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium","volume":"249","author":"Wang","year":"2019","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.03.018_bib0460","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/path.5353","article-title":"Oncogenic BRAF and KRAS mutations in endosalpingiosis","volume":"250","author":"Chui","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcancer.2021.03.018_bib0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101700","article-title":"Increased association of ovarian cancer in women with histological proven endosalpingiosis","volume":"65","author":"Hermens","year":"2020","journal-title":"Cancer Epidemiol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0470","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/jog.13845","article-title":"Sectioning and extensively examining the fimbriated end (SEE-FIM) of the fallopian tube in routine practices, is it worth the effort?","volume":"45","author":"Laokulrath","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"4","key":"10.1016\/j.semcancer.2021.03.018_bib0475","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PGP.0b013e3181c713a8","article-title":"Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications","volume":"29","author":"Carlson","year":"2010","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.semcancer.2021.03.018_bib0480","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ctrv.2018.06.004","article-title":"Fallopian tube tumorigenesis and clinical implications for ovarian cancer risk-reduction","volume":"69","author":"Gockley","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.semcancer.2021.03.018_bib0485","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/SPV.0000000000000741","article-title":"Opportunistic salpingectomy at the time of urogynecologic surgery: why, in whom, and how?","volume":"26","author":"Catanzarite","year":"2020","journal-title":"Female Pelvic Med. Reconstr. Surg."},{"issue":"5","key":"10.1016\/j.semcancer.2021.03.018_bib0490","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/bjs.11419","article-title":"Prophylactic salpingectomy for prevention of ovarian cancer at the time of elective laparoscopic cholecystectomy","volume":"107","author":"Tomasch","year":"2020","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0495","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2018.11.009","article-title":"The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction","volume":"152","author":"Subramaniam","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2021.03.018_bib0500","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/ijc.32916","article-title":"Prophylactic salpingectomy for the prevention of ovarian cancer: who should we target?","volume":"147","author":"Kotsopoulos","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2021.03.018_bib0505","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1097\/AOG.0000000000003164","article-title":"Opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention","volume":"133","author":"ACOG Committee Opinion No. 774","year":"2019","journal-title":"Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.semcancer.2021.03.018_bib0510","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/PAS.0b013e318282da7f","article-title":"Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis","volume":"37","author":"Bijron","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.semcancer.2021.03.018_bib0515","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/AOG.0000000000003864","article-title":"Ovarian Cancer After prophylactic salpingectomy in a patient with germline BRCA1 mutation","volume":"135","author":"Lugo Santiago","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.semcancer.2021.03.018_bib0520","first-page":"1870834","article-title":"Primary peritoneal cancer two decades after a bilateral salpingo-oophorectomy","volume":"2019","author":"Rodowa","year":"2019","journal-title":"Case Rep. Obstet. Gynecol."},{"issue":"23","key":"10.1016\/j.semcancer.2021.03.018_bib0525","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1158\/1078-0432.CCR-20-0270","article-title":"Methylomic landscapes of ovarian cancer precursor lesions","volume":"26","author":"Pisanic","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0530","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ygyno.2018.10.002","article-title":"RNA sequencing (RNA-Seq) and its application in ovarian cancer","volume":"152","author":"Wang","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"24","key":"10.1016\/j.semcancer.2021.03.018_bib0535","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1158\/1078-0432.CCR-18-1199","article-title":"Methylomic analysis of ovarian cancers identifies tumor-specific alterations readily detectable in early precursor lesions","volume":"24","author":"Pisanic","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2021.03.018_bib0540","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/CBM-190528","article-title":"Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary","volume":"26","author":"Gutkin","year":"2019","journal-title":"Cancer Biomark."},{"issue":"6","key":"10.1016\/j.semcancer.2021.03.018_bib0545","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/IGC.0000000000000933","article-title":"Changes in the extracellular matrix are associated with the development of serous tubal intraepithelial carcinoma into high-grade serous carcinoma","volume":"27","author":"van der Steen","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2021.03.018_bib0550","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/IGC.0000000000001321","article-title":"Characterization of primary cilia in normal fallopian tube epithelium and serous tubal intraepithelial carcinoma","volume":"28","author":"Abdelhamed","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"10","key":"10.1016\/j.semcancer.2021.03.018_bib0555","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.5858\/arpa.2017-0231-RA","article-title":"Serous tubal intraepithelial carcinoma or not? Metastases to fallopian tube mucosa can masquerade as in situ lesions","volume":"141","author":"Singh","year":"2017","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2021.03.018_bib0560","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0000000000000757","article-title":"Uterine serous carcinomas frequently metastasize to the fallopian tube and can mimic serous tubal intraepithelial carcinoma","volume":"41","author":"Kommoss","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"23","key":"10.1016\/j.semcancer.2021.03.018_bib0565","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-20-3331","article-title":"DNA methylation profiling of premalignant lesions as a path to ovarian Cancer Early detection","volume":"26","author":"Ishak","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0570","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.semcancer.2021.03.018_bib0575","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S1470-2045(19)30340-7","article-title":"Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study","volume":"20","author":"Nen\u00e9","year":"2019","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.03.018_bib0580","first-page":"743","article-title":"Vaginal microbiomes and ovarian cancer: a review","volume":"10","author":"Xu","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0585","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/s41598-020-58507-4","article-title":"A dog oviduct-on-a-chip model of serous tubal intraepithelial carcinoma","volume":"10","author":"de Almeida","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2021.03.018_bib0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102103","article-title":"Organoid models in gynaecological oncology research","volume":"90","author":"Semertzidou","year":"2020","journal-title":"Cancer Treat. Rev."},{"issue":"4","key":"10.1016\/j.semcancer.2021.03.018_bib0595","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stemcr.2020.03.004","article-title":"Developing organoids from ovarian Cancer as experimental and preclinical models","volume":"14","author":"Maenhoudt","year":"2020","journal-title":"Stem Cell Reports"},{"issue":"5","key":"10.1016\/j.semcancer.2021.03.018_bib0600","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0605","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41467-020-15089-z","article-title":"Why the dual origins of high grade serous ovarian cancer matter","volume":"11","author":"Colvin","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.semcancer.2021.03.018_bib0610","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41379-019-0401-y","article-title":"Two types of primary mucinous ovarian tumors can be distinguished based on their origin","volume":"33","author":"Simons","year":"2020","journal-title":"Mod. Pathol."},{"issue":"13","key":"10.1016\/j.semcancer.2021.03.018_bib0615","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.ejca.2015.05.011","article-title":"Molecular changes in endometriosis-associated ovarian clear cell carcinoma","volume":"51","author":"Worley","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2021.03.018_bib0620","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.4934","article-title":"Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?","volume":"243","author":"Cochrane","year":"2017","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.semcancer.2021.03.018_bib0625","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1038\/ncomms7118","article-title":"Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling","volume":"Jan 27","author":"Chandler","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.semcancer.2021.03.018_bib0630","doi-asserted-by":"crossref","first-page":"dju410","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:53:21Z","timestamp":1760918001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X21000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":126,"alternative-id":["S1044579X21000687"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.018","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the \u201cDevil\u201d originate from the fallopian tubes?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}